Literature DB >> 853040

Structure of carbohydrate of hemoglobin AIc.

R J Koenig, S H Blobstein, A Cerami.   

Abstract

Hemoglobin AIc is a minor component of normal adult erythrocytes whose concentration is elevated approximately 2-fold in patients with diabetes mellitus. Previous work suggested that the unique structural feature of hemoglobin AIc is the presence of a low molecular weight sugar moiety at the NH2-terminal valine of the beta chain. In this study the structure of the carbohydrate moiety and the nature of its linkage of the beta chain were investigated. Enzymatic digestion of borohydride-reduced betaAIc chains followed by ion exchange chromatography led to the isolation of two distinct NH2-terminal glycovalylhistidines. Comparison of these glycodipeptides with synthetic glycovalylhistidines by thin layer chromatography, gas-liquid chromatography, and proton magnetic resonance spectroscopy gave direct evidence that the naturally derived materials correspond to glucitol and mannitol valylhistidines. Model reactions showed that glucose and mannose react with valine under mild conditions to form an adduct which upon sodium borohydride reduction yields in both cases glucitol and mannitol valines. This suggests a common intermediate, 1-deoxy-1-(N-valyl)fructose, for both reactions. From these studies we conclude that hemoglobin AIc has, as the NH2 terminus of the beta chain, 1-deoxy-1-(N-valyl)fructose. The possible biosynthetic pathways of hemoglobin AIc are discussed.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 853040

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  43 in total

Review 1.  Glycated haemoglobin in the year 2000.

Authors:  E S Kilpatrick
Journal:  J Clin Pathol       Date:  2000-05       Impact factor: 3.411

Review 2.  Advanced glycation: an important pathological event in diabetic and age related ocular disease.

Authors:  A W Stitt
Journal:  Br J Ophthalmol       Date:  2001-06       Impact factor: 4.638

3.  Glycated haemoglobin and glycated protein and glucose concentrations in necropsy blood samples.

Authors:  W G John; K W Scott; D M Hawcroft
Journal:  J Clin Pathol       Date:  1988-04       Impact factor: 3.411

Review 4.  The clinical use of hemoglobin A1c.

Authors:  Christopher D Saudek; Jessica C Brick
Journal:  J Diabetes Sci Technol       Date:  2009-07-01

Review 5.  [The effect of Maillard reaction products on enzyme reactions].

Authors:  D Schumacher; L W Kroh
Journal:  Z Ernahrungswiss       Date:  1996-09

6.  A surprising journey in translational medicine.

Authors:  Anthony Cerami
Journal:  Mol Med       Date:  2014-12-16       Impact factor: 6.354

7.  Reaction of glycolaldehyde with proteins: latent crosslinking potential of alpha-hydroxyaldehydes.

Authors:  A S Acharya; J M Manning
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

8.  Nonenzymatic glycation of human lens crystallin. Effect of aging and diabetes mellitus.

Authors:  R L Garlick; J S Mazer; L T Chylack; W H Tung; H F Bunn
Journal:  J Clin Invest       Date:  1984-11       Impact factor: 14.808

9.  Red cell life span heterogeneity in hematologically normal people is sufficient to alter HbA1c.

Authors:  Robert M Cohen; Robert S Franco; Paramjit K Khera; Eric P Smith; Christopher J Lindsell; Peter J Ciraolo; Mary B Palascak; Clinton H Joiner
Journal:  Blood       Date:  2008-08-11       Impact factor: 22.113

10.  Radioimmunoassay for the determination of glycated haemoglobin.

Authors:  Z Makita; H Nakayama; S Taneda; M Kato; Y Kuroda; S Aoki; K Misawa; S Nakagawa
Journal:  Diabetologia       Date:  1991-01       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.